+ Watch PCYC
on My Watchlist
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
1 star caps rating? another reason why we should not rely on the so called TMF pros. Good lesson of humility for some of them.Immunokinases are a hot target these days, as hot as the multibillion market opportunity of hematological cancers. Of course, any safety/efficacy issues and the stock will tank hard
yea up 400% in a year. no investors will cut a profit
keep your fingers crossed, because the trials are finding drug not effective at the present tested dose.
THe posts here are hilarious. The lack of knowledge about this company by the posters is ASTONISHING. I guess that's the way it is though - just like money managers for the masses - ignorant as could be about companies and follow each other like lemmings.
and mali youre so good at this thats why you picked one company in all this time? i must know something with 200 active picks and a high score sweetie :)
trackjak - I'm not into pretend money making. You REALLY missed the boat on this one. Don't worry, there is more to come - even after early approval for MCL this is still a 20 bagger.
Told yah! Stick with me.INFI is next.
It's a scam. This company is staffed with scientology criminals. CEO Robert Duggan is scientology's largest donor and was also ponzi schemer, Reed Slatkin's mentor. Google is your friendOh, and Mali is also in on the scam.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions